Sichuan Kelun Pharmaceutical Hits Day High with 3.63% Intraday Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a notable increase of 3.63% on March 5, 2026, reaching an intraday high of CNY 30.63. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.26% on the same day. Despite today's gains, the company's performance over the past week shows a slight decline of 0.66%, and it has faced challenges over the past month with a decrease of 3.81%. Year-to-date, Sichuan Kelun has managed a modest increase of 3.17%, outperforming the Shanghai Composite's 2.85% gain. However, the company has struggled over the longer term, with a 3.07% decline over the past year and a 7.91% drop over the last three years, significantly lagging behind the Shanghai Composite's 24.3% growth during that period. Key financial metrics indicate a market capitalization of CNY 36,978 million and a price-to-earnings ratio of 26.00. The company's return on equity stands at 7.03%, while its dividend yield is reported at 2.41%.